ADMS - Adamas Pharmaceuticals Inc.'s (ADMS) CEO Neil McFarlane on Q4 2019 Results - Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS)
Q4 2019 Results Earnings Conference Call
February 25, 2020, 04:30 PM ET
Company Participants
Peter Vozzo - Investor Relations, Westwicke Partners
Neil McFarlane - CEO & Director
Christopher Prentiss - Chief Financial Officer
Vijay Shreedhar - Chief Commercial Officer
Conference Call Participants
Marc Goodman - LEERINK Partners LLC
Jason Butler - JMP Securities, LLC
David Amsellem - Piper Sandler
Tim Lugo - William Blair
Serge Belanger - Needham & Company
Raghuram Selvaraju - H.C. Wainwright
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Adamas Fourth